Takeda's Zika vaccine gets U.S. FDA's 'fast track' status | | (Reuters) - Japan's Takeda Pharmaceutical Co Ltd said on Monday the U.S. Food and Drug Administration had granted 'fast track' status to its vaccine for the mosquito-borne Zika virus, which erupted as a major public hazard in Brazil three years ago. |
| |
Ireland to hold abortion referendum at the end of May | | DUBLIN (Reuters) - Ireland's government on Monday proposed holding a referendum to liberalize the country's abortion regime at the end of May, offering voters the first opportunity in 35 years to overhaul some of the world's strictest laws. |
| |
How Sanofi's setback could lead to better dengue vaccines | | CHICAGO (Reuters) - New dengue vaccines being developed by Takeda Pharmaceuticals Co Ltd and U.S. government scientists are poised to provide a safer alternative to Sanofi's Dengvaxia, according to vaccine experts, because they already take into account some of the issues that sidelined the product last year. |
| |
Sleep apnea patients may not always need specialists | | (Reuters Health) - Some patients with a common nighttime breathing disorder known as obstructive sleep apnea may do just as well at managing the condition when they see a primary care provider instead of a specialist, a research review suggests. |
| |
| | |